Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events?

Journal of the American College of Cardiology

Volumn 39, Issue 3, 2002, Pages 521-522

  Bing, Richard J ^a   Lomnicka, Magdalena ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; ROFECOXIB; THROMBOXANE;

ARTHRITIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG INDUCED DISEASE; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SHORT SURVEY; THROMBOGENESIS; THROMBOSIS;

EID: 0037028635     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01749-1     Document Type: Editorial

References (18)

1. Prostaglandin endoperoxide-h synthases (cyclooxygenases)-1 and -2
2. A new look at myocardial infarction toward a better aspirin
3. Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer
4. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications
5. Risk of cardiovascular events associated with selective COX-2 inhibitors
6. Prostaglandin-like substance appearing in canine renal venous blood during renal ischemia
7. Prostaglandin release by the isolated perfused rabbit heart
8. A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart
9. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin
10. The arachidonic acid metabolic capacity of canine myocardium is increased during healing of acute myocardial infarction
11. Prostaglandin and thromboxane production by human and guinea-pig macrophages and leukocytes
12. Myocardial ischemia and infarction: Growth of ideas
13. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line
14. Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
15. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ
16. Cyclooxygenase expression in bovine aortic endothelial cells exposed to cyclic strain
17. The pharmacology of a new nitric oxide donor: B-NOD